Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease

A. J. H. Moonen*, A. Wijers, A. F. G. Leentjens, C. W. Christine, S. A. Factor, J. Juncos, J. M. Lyness, L. Marsh, M. Panisset, R. Pfeiffer, D. Rottenberg, C. Serrano Ramos, L. Shulman, C. Singer, J. Slevin, W. McDonald, P. Auinger, I. H. Richard

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)644-646
JournalParkinsonism & Related Disorders
Issue number6
Publication statusPublished - Jun 2014


  • Parkinson's disease
  • Depression
  • Clinical trials randomized controlled
  • Venlafaxine
  • Paroxetine

Cite this